Newsroom press releases

21/12/18 - 11:30

DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)

Products Molecular

19/11/18 - 15:00

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)

Products Molecular

17/10/18 - 11:51

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)

Products Molecular

12/10/18 - 11:47

DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)

Products Molecular

17/09/18 - 11:28

DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)

Products Immunodiagnostic

27/07/18 - 12:00

DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)

Products Immunodiagnostic

12/06/18 - 14:15

DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)

Products Molecular

05/04/18 - 12:00

DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)

Products Immunodiagnostic

28/03/18 - 18:45

DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)

Products Molecular

09/09/15 - 2:00

DiaSorin launches the two fastest molecular diagnostic tests in the world to detect fulminant leukemias (229.24 KB)

Products Molecular

28/05/15 - 2:00

DiaSorin launches the test for Campylobacter (241.86 KB)

Products Immunodiagnostic

29/04/15 - 2:00

DiaSorin - launches the test for Brahms-Sepsis (506.96 KB)

Products Immunodiagnostic

14/04/15 - 2:00

DiaSorin launches the tests for Bordetella pertussis (187.11 KB)

Products Immunodiagnostic

14/01/15 - 1:00

DiaSorin launches the test for Calprotectin (259.67 KB)

Products Immunodiagnostic